These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12957086)

  • 1. Simple deliverable therapy needed for childhood leukaemia.
    Lilleyman J
    Lancet; 2003 Aug; 362(9385):676-7. PubMed ID: 12957086
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries.
    Metzger ML; Howard SC; Fu LC; Peña A; Stefan R; Hancock ML; Zhang Z; Pui CH; Wilimas J; Ribeiro RC
    Lancet; 2003 Aug; 362(9385):706-8. PubMed ID: 12957095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All children have a right to full access to treatment for cancer.
    Eden T; Pui CH; Schrappe M; Tognoni G; Masera G; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1121-2. PubMed ID: 15451211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Induction chemotherapy in childhood acute lymphoblastic leukemia: the association between the intensity of therapy and cure].
    Li CK
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):321-3. PubMed ID: 17697613
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of adult acute lymphoblastic leukaemia.
    Stryckmans P; Debusscher L
    Baillieres Clin Haematol; 1991 Jan; 4(1):115-30. PubMed ID: 2039854
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of childhood acute lymphoblastic leukaemia after induction therapy--3 years experience at a single paediatric oncology centre.
    Rana ZA; Rabbani MW; Sheikh MA; Khan AA
    J Ayub Med Coll Abbottabad; 2009; 21(4):150-3. PubMed ID: 21067050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
    Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
    [No Abstract]   [Full Text] [Related]  

  • 9. The million dollar question.
    Cobbs LS; Clark PA; Brusa M
    Hastings Cent Rep; 2000; 30(5):24; discussion 24-6. PubMed ID: 11057383
    [No Abstract]   [Full Text] [Related]  

  • 10. [A brief history of treatments for childhood acute lymphoblastic leukaemia].
    Leverger G; Baruchel A; Schaison G
    Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
    Pinheiro JP; Boos J
    Br J Haematol; 2004 Apr; 125(2):117-27. PubMed ID: 15059133
    [No Abstract]   [Full Text] [Related]  

  • 12. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-risk acute lymphoblastic leukemia].
    Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
    Sońta-Jakimczyk D; Olejnik I; Armata J; Bogusławska-Jaworska J; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Chybicka A; Derwich K; Drabko K; Hicke-Roberts A; Kubiczek K; Steczowicz M
    Wiad Lek; 1998; 51 Suppl 4():52-8. PubMed ID: 10731944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of allogeneic haematopoietic stem cell transplantation in the outcome of Ph+ acute lymphoblastic leukaemia treated with an imatinib-containing regimen.
    Costa LJ
    Br J Haematol; 2009 Sep; 146(5):576-7. PubMed ID: 19555375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute lymphoblastic leukemia in a patient with congenital hemolytic anemia: case report].
    Magyarosy E; Marosi A; Apjok E
    Orv Hetil; 2001 Oct; 142(43):2381-2. PubMed ID: 11760456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America.
    Gupta S; Antillon FA; Bonilla M; Fu L; Howard SC; Ribeiro RC; Sung L
    Cancer; 2011 Oct; 117(20):4788-95. PubMed ID: 21446043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.
    Hunger SP; Sung L; Howard SC
    Pediatr Blood Cancer; 2009 May; 52(5):559-65. PubMed ID: 19127567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone relapse in a patient with acute lymphoblastic leukaemia.
    Aydogdu I; Erkurt AM; Kaya E; Kuku I
    Br J Haematol; 2005 Apr; 129(2):163. PubMed ID: 15813842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.